Phase IIIMitochondrial Peptide
Compound 61550
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061550
Risk Class
LOW
Last Audit
Apr 5, 2108
Research Abstract
Mitochondrial Peptide candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61550 is a mitochondrial peptide asset inside mitochondrial peptide innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in phase iii with a low risk rating, meaning it is cleared for baseline monitoring protocols.
Supply records cite CAS AUTO-061550 with updates logged 2108-04-05.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61550Mitochondrial Peptide Program 61550
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061550
- [2] Operations Pulse • Mitochondrial Peptide innovation track
- [3] Risk Governance Ledger • LOW clearance for COMPOUND-61550